FDA Inspection 1082505 — Vivere Arizona Reproductive Institute, LLC
The FDA completed an inspection of Vivere Arizona Reproductive Institute, LLC on Feb 7, 2019 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 7, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tucson, AZ (United States)